A detailed history of Tranquilli Financial Advisor LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tranquilli Financial Advisor LLC holds 5,188 shares of BMY stock, worth $291,669. This represents 0.17% of its overall portfolio holdings.

Number of Shares
5,188
Previous 5,156 0.62%
Holding current value
$291,669
Previous $214,000 25.23%
% of portfolio
0.17%
Previous 0.14%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $1,269 - $1,656
32 Added 0.62%
5,188 $268,000
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $241 - $317
-6 Reduced 0.12%
5,156 $214,000
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $17,176 - $19,475
358 Added 7.45%
5,162 $279,000
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $44,116 - $52,643
-910 Reduced 15.93%
4,804 $246,000
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $9,088 - $10,162
157 Added 2.83%
5,714 $331,000
Q2 2023

Jul 27, 2023

SELL
$63.71 - $70.74 $19,367 - $21,504
-304 Reduced 5.19%
5,557 $355,000
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $20,567 - $23,327
313 Added 5.64%
5,861 $406,000
Q4 2022

Feb 08, 2023

BUY
$68.48 - $81.09 $3,766 - $4,459
55 Added 1.0%
5,548 $399,000
Q3 2022

Nov 02, 2022

BUY
$0.13 - $76.84 $3 - $2,151
28 Added 0.51%
5,493 $390,000
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $42,046 - $46,308
579 Added 11.85%
5,465 $421,000
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $17,952 - $21,526
292 Added 6.36%
4,886 $357,000
Q4 2021

Feb 10, 2022

SELL
$53.63 - $62.52 $2,681 - $3,126
-50 Reduced 1.08%
4,594 $286,000
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $15,903 - $17,886
268 Added 6.12%
4,644 $293,000
Q4 2020

Feb 25, 2021

BUY
$57.74 - $65.43 $252,670 - $286,321
4,376 New
4,376 $271,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tranquilli Financial Advisor LLC Portfolio

Follow Tranquilli Financial Advisor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tranquilli Financial Advisor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tranquilli Financial Advisor LLC with notifications on news.